AI assistant
SURMODICS INC — Director's Dealing 2020
Jul 6, 2020
32845_dirs_2020-07-06_7c591154-8b72-4e27-a2ca-a788a7790f47.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2020-07-01
Reporting Person: Maharaj Gary R (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-07-01 | Common Stock | S | 2000 | $43.0183 | Disposed | 141142 | Direct |
Footnotes
F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2020.
F2: Reflects the weighted average price of 2,000 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on July 1, 2020 with sale prices ranging from $42.62 to $43.27 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Includes 257 shares acquired through the Employee Stock Purchase Plan for the phase ending 02/28/20.